Some mechanism-based inhibitors cause irreversible inhibition by forming a metabolic intermediate complex (MIC) with the cytochrome P450 (CYP). In the present study, 54 molecules (substrates of CYP3A and amine-containing compounds that are not known substrates of CYP3A) were spectrophotometrically assessed for their propensity to cause MIC formation with recombinant CYP3A4 (+b 5 ). Comparisons of common physicochemical properties showed that mean (± s.d.) molecular weight (MW) of MIC forming compounds was significantly greater than mean MW of non-MIC forming compounds, 472 (± 173) vs. 307 (± 137), respectively. Computational pharmacophores, logistic regression and recursive partitioning (RP) approaches were applied to predict MIC formation from molecular structure and to generate a quantitative structure activity relationship (QSAR). A pharmacophore built with SKF-525A, erythromycin, amprenavir, and norverapamil indicated that four hydrophobic features and a hydrogen bond acceptor were important for these MIC forming compounds. Two different RP methods using either simple descriptors or 2D augmented atom descriptors indicated that hydrophobic and hydrogen bond acceptor features were required for MIC formation. Both of these RP methods correctly predicted the MIC formation status with CYP3A4 for 10 out of 12 literature molecules in an independent test set. Logistic multiple regression and a third classification tree model predicted 11 out of 12 molecules correctly. Both models possessed a hydrogen bond acceptor and represent an approach for predicting CYP3A4 MIC formation that can be improved using more data and molecular descriptors. The preliminary pharmacophores provide structural insights that complement those for CYP3A4 inhibitors and substrates.
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The cytochrome P450 (CYP) enzymes (EC 1.14.14.1) are membrane-bound proteins that catalyze many oxidations of hydrophobic endobiotics and xenobiotics. The catalytic activity of CYPs may be reduced by reversible and irreversible inhibition upon administration of xenobiotics. One type of irreversible inhibition, mechanism-based inhibition, has been the focus of many studies related to CYPs recently due to its clinical implications for prediction of drug-drug interactions. A mechanismbased inhibitor is one that binds to the active site, then becomes catalytically activated by the enzyme (Silverman, 1988) . The activated form of the molecule will irreversibly bind to the enzyme to remove it from the active enzyme pool. Some mechanism-based inhibitors cause this irreversible inhibition by forming a metabolic intermediate complex (MIC) with the heme of the CYP (Franklin, 1977) .
Primary, secondary or tertiary amines, or methylenedioxy constituents (Supplemental Figure 1) , in the molecule are prerequisites for compounds that chelate the heme of the CYP (Franklin, 1977) . More recent studies with metabolites of molecules such as indinavir and nelfinavir that lack these functional groups yet still display MIC formation may indicate other chemical moieties are also involved (Ernest et al., 2005) .
The CYP3A family of enzymes is recognized as perhaps the most important for human drug metabolism as they metabolize the majority of commercially available drugs (Wrighton et al., 2000) .
These CYPs are expressed in numerous tissues but affect xenobiotic metabolism and clearance mainly in the liver and small intestine. There are four differentially regulated CYP3A genes in humans, CYP3A4, CYP3A5, CYP3A7 and CYP3A43, of which, CYP3A4 is the most abundant form in the adult liver (Wrighton et al., 2000) . The CYP3A forms demonstrate regioselectivity differences for some biotransformations of the same compounds, while CYP3A5 generally has lower or comparable metabolic capability than CYP3A4 for common probe substrates (Williams et al., 2002) .
In early pharmaceutical drug discovery the assessment of inhibitory potency with CYP3A4 for new chemical entities is often included as a first tier in vitro screen using fluorescent probes (Crespi and Stresser, 2000) . This type of screen is useful for identifying potential inhibition of co-DMD #14613 5 administered drugs and is commonly followed by time dependent inhibition studies (Wu et al., 2003) .
These studies may be supplemented with additional in vitro assays with more traditional drug substrate probes using LC/MS analysis (Ekins et al., 2000b) . Data from all of these in vitro screens are increasingly applied to predictive algorithm development (Ekins et al., 2003a; Ekins et al., 2003b; Gao et al., 2002; Riley et al., 2001) . The interest in computational models based on in vitro data for predicting potential drug interactions via this protein and others (Ekins and Swaan, 2004 ) represents a possible means to improve productivity of the drug discovery process and remove potential bottlenecks caused by in vitro testing. Due to their highly parallel nature computational methods are also likely the fastest and most cost-effective method for indication of likely toxic consequences (Ekins et al., 2000a) , and suggesting new hypotheses for testing in vitro. A recent review of computational methods for CYPs has documented how these approaches have been used over nearly twenty years alongside empirical methods (de Graaf et al., 2005) . Others have described and compared the many pharmacophores that have been generated for CYPs (de Groot and Ekins, 2002; Ekins et al., 2001) providing insight into the important features for interaction of ligands and the proteins. Computational pharmacophores for CYP3A4 have therefore been derived for substrates and inhibitors using kinetic constants K m , K i (apparent) and IC 50 data. Several studies have shown differential MIC formation for compounds between CYP3A4 and CYP3A5. For example CYP3A5 did not form a MIC with verapamil (Wang et al., 2004) or saquinivir (Ernest et al., 2005) . These differences suggest that the binding sites (and catalytic rate) for both enzymes are subtly different accommodating some molecules and not others as has been suggested by recent pharmacophores for inhibitors of both enzymes (Ekins et al., 2003b) .
In the present study 54 molecules have been assessed for their propensity to form MIC while 27 molecules possess k inact data with recombinant CYP3A4 in vitro. These data have been analyzed along with the generation of simple molecular descriptors to understand any possible relationships between MIC, k inact and molecule structure. Several computational approaches namely, pharmacophores, DMD #14613 6 quantitative structure activity relationships (QSAR) (Ekins and Swaan, 2004) , classification tree, and multiple regression methods were used to generate models to predict these properties separately. These models were applied to the prediction of the probability of a molecule forming an MIC with CYP3A4 using a series of test molecules, while the k inact models were internally validated by omitting molecules at random. (Ernest et al., 2005) . The concentration of 6β-hydroxytestosterone was determined by HPLC with UV detection as described earlier (Zhao et al., 2002) . The mechanism-based inactivation parameters, k inact and K I , were obtained from the pseudo first order decline in the percentage of remaining CYP3A4 activity after preincubation with inactivator by nonlinear regression without weighting using WinNonlin Professional, v 4.0 (Pharsight, Mountain View, CA). Details of the data fitting and parameter estimation have been described previously (Ernest et al., 2005) .
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MATERIALS AND METHODS
Chemicals
Metabolic Intermediate Complex Measurements. MIC formation was identified using dual wavelength spectroscopy (Uvikon 933 double beam UV/VIS Spectrophotometer; Research Instruments International, San Diego, CA) by scanning from 380 to 500 nm. The sample cuvette contained protein (200 pmol of CYP3A4 (+b 5 )), 100 mM sodium phosphate buffer (pH = 7.4), inhibitor, and 1 mM NADPH (made with the phosphate buffer), whereas the reference cuvette contained protein, 100 mM phosphate buffer, vehicle, and 1 mM NADPH. All MIC formation experiments were initiated by the addition of NADPH and maintained at 37°C. The absorbance difference spectra for the identification of MIC formation were estimated by subtracting the absorbance at 490 nm of the absorbance scan from the difference of the absorbance scan at 60 min and DMD #14613 9 a background absorbance scan. MIC formation was quantified from absorbance difference spectra using an extinction coefficient of 65 mM -1 cm -1 (Pershing and Franklin, 1982 Pharmacophores for MIC prediction. The Catalyst software was used on a Silicon Graphics Octane workstation. After importing the molecular structures, conformers were generated for each compound using the BEST functionality for each molecule and limited to a maximum of 255 conformers with an energy range of 20 kcal/mol. Structural relationships between compounds that form MIC and those that do not form MIC were assessed separately using the common features function (HIPHOP). The following groups of molecules were selected in order to test the fit of the hypothesis with unknowns: Compounds that form MIC (SKF-525A, erythromycin, amprenavir, norverapamil), compounds that do not form MIC (mifepristone, sertraline, 4-hydroxytamoxifen, and paroxetine), and compounds that do not form MIC but inactivate CYP3A4 (lopinavir, saquinavir, nefazodone). These alignments were then used to fit molecules to the hypothesis.
Recursive partitioning (ChemTree) for MIC prediction. The ChemTree recursive partitioning software was run on a Pentium 4 processor. The 54 molecules and experimental data (binary response;
1= compound that forms MIC, 0 = compound that does not form detectable MIC) were imported as a DMD #14613
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.sdf file in ChemTree to generate over 330 path length descriptors (Young et al., 2002) . These descriptors were used to generate either 1 tree or 100 random tree models (with the following options; p value threshold for splits, 0.99; max segments, 3; parallel threads, 1; and resampling iterations, 10,000).
Recursive partitioning (Cerius 2 CSAR) for MIC prediction. The Cerius 2 4.8 software was used to generate the following default descriptors: sum of atomic polarizabilities, dipole magnitude, radius of gyration, area, molecular weight (MW), molecular volume, density, principal moment of inertia, rotatable bonds, hydrogen bond acceptors, hydrogen bond donors, and AlogP98 (a second method for calculating the octanol-water partition coefficient). The CSAR recursive partitioning method (Hawkins et al., 1997) was used with the 54 molecule training set (with the following settings, using weighted observations equally, gini scoring, scaled prune (0)). This model was internally validated using crossvalidation: e.g. 10-fold, five-fold, or two-fold. A 10-fold cross-validation leaves out 10% test data.
Recursive partitioning (tree function in R) for MIC prediction. The R v2.2.1 software was used to predict MIC formation based on the twelve prescribed descriptors. The recursive partitioning method (Breiman et al., 1984) was used with the 54 molecule training set (with weighted observations equally and gini scoring). This model was internally validated using five-fold cross-validation, and the tree is pruned based on misclassification.
Logistic Regression for MIC prediction. Logistic regression model was implemented in a R
function, generalized linearized model, glm() (R v 2.2.1; www.r-project.org). The model was generated with the twelve Cerius 2 descriptors to predict MIC formation. Fifty four compounds served as the training set. The glm() algorithm is based on the maximizing likelihood approach. A forward step-wise forward variable selection strategy was used to select descriptors. The optimal model was internally validated based on a five-fold cross-validation.
Pharmacophore, tree models, and the logistic regression model were tested with molecules outside of the training set using recently published data for twelve compounds (Chatterjee and DMD #14613
11 Franklin, 2003; Kajita et al., 2002; Kasahara et al., 2000; Kim et al., 2001; Wu et al., 2003; Yamazaki and Shimada, 1998) with MIC formation for CYP3A4 (Table 3) .
Linear Multiple Regression and Regression Tree Models for k inact , K I , and k inact /K I prediction.
The k inact and K I values were estimated from in vitro studies with 27 compounds as described previously. Linear multiple regression and regression tree models were fit with the twelve descriptors, listed in the recursive partitioning section above, to predict k inact , K I , k inact /K I . Stratified randomization was utilized to divide samples into three strata based on 33 percentile and 67 percentile of k inact and/or K I values. Within each stratum, 2/3 of the samples (n=18) were randomly selected into the training set and the remaining 1/3 (n=9) were selected into the external validation set. All variables were logtransformed.
Two R functions, linear model, lm(), and tree() (R v 2.2.1), were implemented for regression tree model construction. These two predictive models were based on five-fold cross-validation on training set samples. out of 330 general descriptors that were initially generated. This model misclassified seven molecules in the training set based on a score less than 0.5 for compounds that do not form MIC and a score greater than 0.5 for compounds that do form MIC, such that 87 % were correctly predicted ( Table 2 ).
RESULTS
Formation of Metabolic
The 100 random tree model generated with the same training set used 21 out of the 330 available descriptors. The most frequently used descriptors were C(CCC)-N(CC), C(CCC)-C(CCC), C(CCC)-
C(CN), C(N)-C(O) and C(CC)-N(CC) (representing connectivity between the atoms listed). When the DMD #14613
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The single tree and 100 tree models both incorrectly assigned two of the twelve compounds in the validation test set (Supplemental Figure 3) representative of 83 % accuracy (Table 3) . These compounds were olopatadine M1 and miocamycin.
Recursive partitioning (Cerius 2 CSAR) for MIC prediction. The second recursive partitioning tree model was generated with twelve descriptors in Cerius 2 ( Figure 5 and Supplemental Table 1 available online only). This CSAR model classified correctly all of the molecules in the training set using the same 54 compounds that were utilized in the ChemTree models. This model was internally validated using 10-fold, 5-fold, and 2-fold cross validation, resulting in 74 %, 80 % and 76 % correct predictions, respectively. This stability in the predictions for the left out molecules perhaps also suggests the stable nature of this model for external testing.
This model incorrectly assigned roxithromycin M2 and M3 as non MIC forming and miocamycin as MIC forming, three of twelve compounds, in the validation test set, which represents 75 % accuracy (Table 3 ).
The combination of Cerius 2 molecular descriptors with ChemTree descriptors enabled another 100 tree model to be built with ChemTree. This used 37 of 342 available descriptors. The most frequently used descriptors in addition to those path length descriptors previously mentioned, included the radius of gyration from the Cerius 2 descriptors. This 100 tree ChemTree recursive partitioning model was used to generate predictions for molecules that were not in the training set and the mean score determined as described above. This model was used to score the validation set of literature molecules for MIC formation and incorrectly assigned olopatidine M1 and miocamycin as MIC forming, two of twelve which represents 83 % accuracy (Table 3) .
Recursive partitioning (tree function in R) for MIC prediction. Another recursive partitioning tree model (logistic model tree function in R) was generated using the twelve descriptors from Cerius 2 ( Figure 6 and Supplemental Table 1 available online only). This tree model was formed by optimizing the gini function. It was then pruned by minimizing the misclassification rate in a five-fold crossvalidation. The final tree model for the 54 training set molecules classified correctly 96 % of the molecules in the training set and contained hydrogen bond acceptor, radius of gyration, sum of atomic polarization, and dipole magnitude descriptors. This model was also used to predict the tendency of the literature test set molecules to form a MIC. Among twelve compounds in the external validation set, the model incorrectly assigned miocamycin as MIC forming, which relates to 92 % accuracy (Table 3) .
Logistic Regression Model for MIC prediction. Logistic regression was generated with a R function generalized linear model (glm) and the twelve Cerius 2 molecular descriptors (supplemental Table 1 ) to predict MIC formation. Logistic regression utilizes a logit transformation of descriptors in linear combinations to predict the probability of a binary outcome variable. Usually, maximum likelihood estimation is utilized for estimating regression parameters. Fifty four drug compounds served as the training set (Table 2) , and twelve compounds represented the external validation set (Table 3 ). The step-wise feed forward procedure was chosen to select and optimize prediction model.
The internal validation was based on a five-fold cross-validation.
The logistic regression training data produced a predictive model in which the hydrogen bond acceptor descriptor was the most important predictor (p-value = 0.002). The following equation was used to predict MIC formation applying the hydrogen bond acceptor descriptor. 
The logistic regression model had 80 % prediction accuracy for the 54 compounds in the training set. Among 12 compounds in the external validation set, it incorrectly assigned miocamycin as MIC forming, which represents 92 % prediction accuracy (Table 3) .
Regression Tree Models for k inact , K I , and k inact /K I prediction.
Recursive partitioning tree models (tree function in R) were generated with twelve descriptors in Cerius 2 (Table 1 
DISCUSSION
Considerable research has focused on computational algorithms that can be used in drug discovery for predicting molecular properties. These include rule based models for predicting the likelihood of absorption (Lipinski et al., 1997) , methods that have more graphical outputs for predicting binding to CYPs (Ekins et al., 2001) or abstract QSAR methods applied to many proteins and properties relevant to ADME/Tox (Ekins and Swaan, 2004) . Such calculations can be performed with very large numbers of molecules to act as a molecule selection filter. Comparative molecular fields analysis (CoMFA) and pharmacophore approaches have been used to model CYP enzymes involved in drug metabolism and which have a role in important drug-drug interactions (de Groot et al., 1999a; de Groot et al., 1999b; de Groot et al., 1996; Ekins et al., 2001; Jones et al., 1996) . Recursive partitioning methods have been used extensively with large sets of molecules and either continuous (Chen et al., 1999; Chen et al., 1998) or binary data, for therapeutic target end points as well as CYP inhibition (Ekins et al., 2003a) and toxicity properties such as AMES mutagenicity status (Young et al., 2002) . Linear regression is perhaps one of the earliest approaches used for QSAR of P450 (Hansch and Zhang, 1993) . The goal of a logistic regression analysis is to find the best fitting, and most parsimonious probabilistic model to describe the relationship between an outcome and a set of predictors. What distinguishes the logistic regression model from the linear regression model is that the outcome variable in logistic regression is categorical. In fitting the logistic regression model, a maximum likelihood based approach is used to estimate the regression parameters (Hosmer and Lemeshow, 1989) . Logistic regression analysis has been used for a QSAR modeling antibacterial study (Cronin et al., 2002) as well as in other areas. In the present study we have applied pharmacophore, recursive partitioning and logistic regression methods to aid in discriminating between MIC forming compounds and those which do not form an
MIC.
A preliminary comparison between CYP3A4 (+b 5 ) MIC and non-MIC forming compounds based on the mean molecular weight showed a significant difference between the two groups of compounds DMD #14613
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(p < 0.05) indicating that larger molecules are more likely to form MIC in vitro with CYP3A4 (+b 5 ).
Another comparison was done on compounds that were CYP3A4 substrates compared to non CYP3A4
substrates, which resulted in a similar outcome, i.e. there was a significant difference in the molecular weights between the two groups. This difference may be due to the specific set of data used in our study (the macrolide antibiotics and anti-HIV compounds tend to have higher molecular weights) and may not be a universal characteristic of substrates/inhibitors of CYP3A4. However there was no significant difference between the ClogP between the two groups of compounds. The qualitative approach of common feature pharmacophore alignments (Catalyst, 2003) for selected compounds suggests that CYP3A4 (+b 5 ) MIC formation requires at least multiple (four) hydrophobic interactions and a hydrogen bond acceptor interaction. Conversely, non-MIC forming compounds appear to possess fewer hydrophobic pharmacophore features with hydrogen bond donor rather than acceptor interactions ( Figure 1 ). Molecules that are inactivators but apparently do not form an MIC also appear to be generally larger with more hydrophobic and hydrogen bond acceptor features that MIC and non-MIC forming compounds.
The recursive partitioning approach confirmed these findings to some extent, as a key descriptor in the ChemTree lowest rms scoring tree for the first split was C(N)-O(CC). This highlights a hydrophobic interaction while the second split C(CCC)-C(CN) is likely to represent a hydrogen bond acceptor interaction some distance from a hydrophobic feature. The key molecular descriptors used in all models as well as the summary of the training and test set correlations are described in Table 5 .
Similarly, in the single tree ChemTree model (Figure 3 ) selected for comparison with this multiple tree model, the descriptor C(CCC)-C(O) represents the hydrogen bond acceptor while the descriptor C(CCC)-N(CC) represents the hydrophobic interaction. When the different molecular descriptors generated in Cerius 2 CSAR were used with the ChemTree descriptors, different recursive partitioning models can be produced that suggest the radius of gyration is an important descriptor as well. This is interesting as the initial Cerius 2 CSAR tree model does not include any splits based on this descriptor.
The radius of gyration is calculated using the following equation: The linear and regression tree models for k inact , K I , and k inact /K I prediction produced poor statistics for training and testing. In addition, there was no consistency on the selected molecular descriptors among the optimal prediction models. This potentially indicates either limitations in the feature set or the complexity of modeling such parameters with these methods alone.
The presence of an amine function does not always imply that a molecule will form a MIC (Kajita et al., 2002) . For example, 3-hydroxy tamoxifen and 4-hydroxy tamoxifen do not form MIC while tamoxifen and n-desmethyltamoxifen form MIC in vitro (Zhao et al., 2002) . Some macrolide antibiotics such as clarithromycin form MIC (Mayhew et al., 2000) while others like miocamycin do not (Kasahara et al., 2000) , which suggests the amine may be sterically hindered in the later case such that it cannot orientate correctly in the CYP3A4 (+b 5 ) binding site. This type of interaction may not be picked up with the 2D-QSAR tree methods and may result in the misclassifications observed.
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It would also appear that requirements for CYP3A4 (+b 5 ) mediated MIC formation requires other molecular properties besides primary, secondary, tertiary amines or methylenedioxyphenyl features.
From this study, differentiating between MIC forming and non-MIC forming compounds is apparently complex, likely requiring numerous hydrophobic and hydrogen bond acceptor features for MIC formation. The pharmacophore for MIC forming compounds (Figure 1a ) is similar to previously published pharmacophores for CYP3A4 inhibitors (Ekins et al., 1999a; Ekins et al., 2003b) and autoactivators (Ekins et al., 1999b) indicating that these binding sites may overlap to some extent.
Compounds that inactivate but do not form MIC with CYP3A4 may possess all of these features but be too large overall. This would suggest some important size and molecular feature constraints on binding CYP3A4 (+b 5 ) which lopinavir, saquinavir, and nefazodone appear to exceed as they possess many more molecular features than MIC and non-MIC forming compounds. The non-MIC forming compounds indicate that there may be a minimal set of molecular features for MIC formation to occur.
It is interesting to speculate that these features may impact the orientation of a molecule in the CYP3A4 binding site and the observation of MIC formation. For example the number of rotatable bonds correlates with the molecular weight (r 2 = 0.68, using the data for 54 molecules from Supplemental Table 1 ) and the number of hydrogen bond acceptors also correlates with the molecular weight (r 2 = 0.75, using the data for 54 molecules from Supplemental Table 1 ) and these larger compounds in turn tend to be MIC forming, upto a point. In contrast the correlation between molecular weight and the number of hydrogen bond donors is much lower (r 2 = 0.42 using the data for 54 molecules from Supplemental Table 1 ). This may indicate that molecules with greater conformational flexibility and size can position themselves optimally to form an MIC, while smaller more rigid molecules are less likely to be able to fulfill the key pharmacophore features. However, with increasing conformational flexibility of molecules could come the increased likelihood that fewer of the MIC formation events become observable with our current detection method, as many of the population of conformations do not result in MIC formation. A recent X-ray structure of the MIC forming compound DMD #14613
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Erythromycin in CYP3A4 did not suggest the molecule was in a productive binding mode as the site of metabolism was too far from the heme (Ekroos and Sjogren, 2006 ), yet the authors did not indicate whether the orientation could result in the MIC.
It is important to note that this present study used molecular descriptors calculated on the parent molecule to predict MIC formation, when in fact a metabolite is actually binding to the heme.
Our results would indicate that the descriptors selected from the parent molecules are transferable to capture the important features in the metabolites. This in itself may be valuable, as our approach therefore does not require the a priori knowledge or prediction of the metabolite/s involved. However once the metabolite/s is known it may be possible to use combined descriptors for the parent and metabolites as demonstrated previously for predicting N-dealkylation (Balakin et al., 2004) . Future work may assess the chemical reactivity of the molecules that form MIC and attempt to determine the binding interactions with heme and elsewhere in the protein using site directed mutagenesis. In addition the models could be further tested with much larger diverse test sets, as those molecules selected in this study from the literature, represent six core structures.
An in vitro model was proposed that can predict the clinically observed inhibition of CYP3A4 after administration of clarithromycin, fluoxetine and diltiazem (Mayhew et al., 2000) . In summary the in vitro rates for loss of CYP3A4 activity were used to predict the in vivo rates. Overall the in vitro-in vivo predictions were in accord with the clinical data. The clinical significance of being able to predict compounds that form MIC in humans is the constant polypharmacy that many humans subject themselves to on a daily basis. If one could predict a priori that a compound will form a MIC in humans and what the k inact value is, then it is possible to remove these types of structures from combinatorial libraries and screening collections. In this manuscript, models were developed and tested for prediction of compounds forming MIC with CYP3A4 (+b 5 ). Ultimately, based on the results in this study, the different QSAR models generated compliment the in vitro testing, representing a preliminary approach to predicting CYP3A4 (+b 5 ) MIC formation that may be improved with the DMD #14613
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addition of further molecules to the training set, different descriptors or other algorithms. These approaches may be equally applicable to naturally occurring compounds as well as to drugs. The modeling methods could also be applied to other CYPs which are known to form MIC (Chatterjee and Franklin, 2003) (Ernest et al., 2005) All data were produced in this study except where explicitly referenced. All data were produced in this study except where explicitly referenced. For predicted MIC formation, a value of > 0.5 was used for MIC formation, a value of < 0.5 for no MIC formation.
* molecules that do not form a MIC but inactivate CYP3A4 + 1 = molecule forms MIC, 0 = molecule does not form MIC DMD #14613
38 Table 3 . Observed and predicted data for molecules in the validation test set. 
Name
